BenchSci, which sells AI-powered software for biopharmaceutical research and development (R&D), says it has struck a ...

A 3-day conference-cum-workshop on “AI-Driven Innovations in Drug Discovery and Agriculture (AI-D2A 2025)” commenced here ...

Artificial intelligence (AI) is on pace to become the most rapidly adopted technology in health care, 1 whether clinicians are ready for it or not. From ambient scribes transcribing doctor-patient ...

Recursion Pharmaceuticals ( RXRX +1.27%) has been a pioneer in using artificial intelligence (AI) to improve the drug ...

From designing proteins not found in nature to extending healthy lifespan, Retro Biosciences is applying AI models to advance cellular reprogramming for aging research. The company operates across ...

Vertex Pharmaceuticals chief Reshma Kewalramani said AI could reduce the time spent on drug-approval paperwork from months to ...

With an AI-led platform for drug discovery and a growing global client base, Medvolt AI is emerging as one of India’s most ...

The Incheon Free Economic Zone (IFEZ) brought together corporations, researchers and academic institutions from around the ...

Traditional drug discovery takes 10-15 years and costs billions. Learn how AI is cutting this time to months, creating new ...

Eli Lilly will partner with Insilico Medicine on an artificial intelligence (AI)-based drug development collaboration that they said could generate “over $100 million” for the AI drug discovery ...

Explore why AI struggles with drug discovery, highlighting the paradox of quantity versus quality in generating effective hypotheses.